Market Research Logo

Chile Pharmaceuticals & Healthcare Q2 2018

Chile Pharmaceuticals & Healthcare Q2 2018

BMI View:

The appearance of Chile on the 2018 PhRMA priority list highlights the continued regulatory concerns in Chile. Thepartial solutions and slow implementation of regulatory regulations will continue to pose downside risks to the pharmaceuticalindustry. The adherence to the conditions in the Chile-US Free Trade Agreement will pose upside risks to the intellectual propertyenvironment.


BMI Industry View
SWOT
Industry Forecast
Pharmaceuticals
Healthcare
Prescription Drug
Patented Drug
Generic Drug
OTC Medicine
Pharmaceutical Trade
Industry Risk/Reward Index
Americas Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Laboratorios Andrómaco
Laboratorios Chile (LabChile)
Merck & Co
Novartis
Pfizer
Sanofi
Corporación Farmacéutica Recalcine
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report